Blueprint Medicines (BPMC) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free BPMC Stock Alerts $108.78 +0.23 (+0.21%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ2 2024 Earnings Estimate for Blueprint Medicines Co. Issued By Leerink Partnrs (NASDAQ:BPMC)americanbankingnews.com - May 9 at 1:24 AMBlueprint Medicines Co. Forecasted to Earn Q2 2024 Earnings of ($1.10) Per Share (NASDAQ:BPMC)marketbeat.com - May 8 at 6:29 AMBlueprint Medicines (NASDAQ:BPMC) PT Raised to $168.00 at The Goldman Sachs Groupamericanbankingnews.com - May 8 at 6:08 AMBlueprint Medicines (NASDAQ:BPMC) Rating Increased to Market Perform at SVB Leerinkamericanbankingnews.com - May 8 at 4:57 AMZacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligandfinance.yahoo.com - May 7 at 8:52 AMBlueprint Medicines (NASDAQ:BPMC) Lifted to "Market Perform" at Leerink Partnrsamericanbankingnews.com - May 7 at 7:28 AMBlueprint Medicines Co. (NASDAQ:BPMC) Forecasted to Earn FY2027 Earnings of $5.34 Per Shareamericanbankingnews.com - May 7 at 7:28 AMBlueprint Medicines (NASDAQ:BPMC) Upgraded to Market Perform at Leerink Partnrsamericanbankingnews.com - May 7 at 6:46 AMBlueprint Medicines Co. (NASDAQ:BPMC) CFO Michael Landsittel Sells 10,000 Shares of Stockamericanbankingnews.com - May 7 at 5:24 AMBlueprint Medicines Co. (NASDAQ:BPMC) Insider Ariel Hurley Sells 1,834 Shares of Stockamericanbankingnews.com - May 7 at 5:24 AMAriel Hurley Sells 1,834 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) Stockinsidertrades.com - May 7 at 4:48 AMMichael Landsittel Sells 10,000 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) Stockinsidertrades.com - May 7 at 4:13 AMLeerink Partners Upgrades Blueprint Medicines (BPMC)msn.com - May 7 at 3:49 AMBlueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)prnewswire.com - May 6 at 4:01 PMBlueprint Medicines (NASDAQ:BPMC) Upgraded at SVB Leerinkmarketbeat.com - May 6 at 8:07 AMCitigroup Boosts Blueprint Medicines (NASDAQ:BPMC) Price Target to $76.00americanbankingnews.com - May 6 at 6:18 AMJMP Securities Raises Blueprint Medicines (NASDAQ:BPMC) Price Target to $125.00americanbankingnews.com - May 6 at 6:18 AMBarclays Boosts Blueprint Medicines (NASDAQ:BPMC) Price Target to $75.00americanbankingnews.com - May 6 at 6:18 AMBlueprint Medicines (NASDAQ:BPMC) Price Target Raised to $135.00americanbankingnews.com - May 6 at 6:18 AMBlueprint Medicines (NASDAQ:BPMC) Upgraded at StockNews.comamericanbankingnews.com - May 6 at 6:18 AMEquities Analysts Offer Predictions for Blueprint Medicines Co.'s Q1 2025 Earnings (NASDAQ:BPMC)americanbankingnews.com - May 6 at 3:34 AMBlueprint Medicines' (BPMC) Buy Rating Reiterated at Needham & Company LLCamericanbankingnews.com - May 6 at 2:48 AMFisher Asset Management LLC Has $30.12 Million Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - May 5 at 8:12 AMBlueprint Medicines (NASDAQ:BPMC) PT Raised to $104.00 at Piper Sandleramericanbankingnews.com - May 5 at 5:12 AMBlueprint Medicines (NASDAQ:BPMC) Reaches New 1-Year High at $107.56americanbankingnews.com - May 4 at 6:32 AMSell/High Risk: Cautious Outlook on Blueprint Medicines Amidst Unsustainable Growth Factorsmarkets.businessinsider.com - May 4 at 12:10 AMBlueprint Medicines Corp (BPMC) (Q1 2024) Earnings Call Transcript Highlights: Surpassing ...finance.yahoo.com - May 4 at 12:10 AMBuy Rating Affirmed for Blueprint Medicines on Strong Financials and Clinical Pipeline Prospectsmarkets.businessinsider.com - May 4 at 12:10 AMBlueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 4 at 12:10 AMBlueprint Medicines (NASDAQ:BPMC) Raised to Hold at StockNews.commarketbeat.com - May 3 at 11:59 PMCitigroup Raises Blueprint Medicines (NASDAQ:BPMC) Price Target to $76.00marketbeat.com - May 3 at 10:15 PMQ1 2024 Blueprint Medicines Corp Earnings Callfinance.yahoo.com - May 3 at 12:55 AMBlueprint Medicines Shares Hit 52-Week on Strong Ayvakit Salesmarketwatch.com - May 2 at 12:54 PMBPMC Stock Earnings: Blueprint Medicines Beats EPS, Beats Revenue for Q1 2024msn.com - May 2 at 12:54 PMBlueprint Medicines Corp Reports Q1 2024 Earnings, Surpasses Revenue Estimates and Raises ...finance.yahoo.com - May 2 at 12:54 PMBlueprint Medicines (NASDAQ:BPMC) Hits New 52-Week High at $107.56marketbeat.com - May 2 at 12:08 PMBlueprint Medicines Corporation 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - May 2 at 11:29 AMBlueprint Medicines (NASDAQ:BPMC) Stock Rating Reaffirmed by Needham & Company LLCmarketbeat.com - May 2 at 8:23 AMBlueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidanceprnewswire.com - May 2 at 7:00 AMJackson Creek Investment Advisors LLC Purchases New Stake in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 30 at 5:34 PMBlueprint Medicines Co. (NASDAQ:BPMC) Given Average Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 30 at 3:12 AMBlueprint Medicines Co. (NASDAQ:BPMC) Receives Average Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 30 at 2:33 AMRigel Pharmaceuticals: No Respect With Little Justification, Worth Considering A Buyseekingalpha.com - April 29 at 8:38 AMFederated Hermes Inc. Buys Shares of 24,043 Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 29 at 5:01 AMState of New Jersey Common Pension Fund D Sells 13,058 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 27 at 8:22 AMRubrik to debut on NYSE, IPO priced at $32 per sharefinance.yahoo.com - April 26 at 3:00 PMStifel Nicolaus Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $130.00marketbeat.com - April 26 at 12:40 PMBlueprint Medicines' (BPMC) "Outperform" Rating Reiterated at Wedbushmarketbeat.com - April 26 at 11:16 AMBlueprint Medicines Corporation: A Strong Buy on Robust Pipeline and Market Potential for Mast Cell Disease Treatmentsmarkets.businessinsider.com - April 26 at 9:59 AMThe Analyst Verdict: Blueprint Medicines In The Eyes Of 7 Expertsmarkets.businessinsider.com - April 26 at 9:59 AM Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… BPMC Media Mentions By Week BPMC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMC News Sentiment▼0.550.36▲Average Medical News Sentiment BPMC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMC Articles This Week▼596▲BPMC Articles Average Week Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ELAN News Today CYTK News Today ITCI News Today JAZZ News Today IONS News Today CERE News Today ASND News Today APLS News Today OGN News Today BBIO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPMC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
